INDBInternet News Database 2.5 Updated just now · 414 sources Show or hide images Light or dark

FDA scientists opposed Trump administration’s move to ease peptide access

4 sources5 articles First seen Updated United States Truth score 66

Save Compare coverage
Image from The Guardian

Summary

(MedPage Today) -- There are "zero" signs that HHS Secretary Robert F. (MedPage Today) -- The Trump administration on Wednesday acted to ease access to unproven peptide drugs favored by Health Secretary Robert F. Covered by 3 outlets: 1 lean left, 2 are centre.

Automated summary picked from the outlets' own descriptions.

Who is covering this

  1. Chron Center Factuality: Mostly factual US
    RFK Jr. eases access to unproven peptides despite opposition from FDA scientists

    Food and Drug Administration staffers had little input on the Trump administration's decision that eases access to peptide drugs favored by Health Secretary Robert F. Kennedy Jr. That’s according to people familiar with the policy’s development who were interviewed by The...

  2. Medpagetoday Center Factuality: Mostly factual US
    RFK Jr. Eases Access to Unproven Peptides Despite Opposition From FDA Scientists

    (MedPage Today) -- The Trump administration on Wednesday acted to ease access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr., and FDA scientific staffers had little input on the decision and opposed the changes, according...

  3. The Guardian Left Factuality: Very high GB
    FDA scientists opposed Trump administration’s move to ease peptide access

    Effort to loosen rules on unproven peptide drugs, favored by RFK Jr, faced fierce pushback from agency scientists A plan to give people in the United States easier access to unproven peptide drugs favored by the US health secretary, Robert F Kennedy Jr , was opposed by most...

  4. Medpagetoday Center Factuality: Mostly factual US
    RFK Jr.'s Future With Trump; 'Metabolic Psychiatry' Appointee; Kratom Ban Backtrack

    (MedPage Today) -- There are "zero" signs that HHS Secretary Robert F. Kennedy Jr. will leave the Trump administration after the midterms. (Axios) Kennedy is reportedly considering Shebani Sethi, MD, a psychiatrist who coined the term "metabolic...

  5. ABC News (US) Leans left Factuality: High US
    FDA scientists opposed the Trump administration's effort to ease peptides access

    Food and Drug Administration scientists did not support an effort by President Donald Trump's administration to loosen rules on unproven peptide drugs

Related stories